gatifloxacin has been researched along with besifloxacin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Brady, SF; Koirala, B; Peek, J | 1 |
| Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Shafiee, A | 2 |
| Hesje, CK; Marquart, ME; Moore, Q; Norcross, EW; Sanders, ME; Sanfilippo, CM; Shafiee, A | 1 |
| Hesje, CK; Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Sanfilippo, CM; Shafiee, A | 1 |
| Proksch, JW; Ward, KW | 1 |
| Haas, W; Hesje, CK; Morris, TW; Pillar, CM; Sanfilippo, CM | 1 |
| Comstock, TL; Donnenfeld, ED; Proksch, JW | 1 |
| Bertino, JS; Jones, RN; Segreti, J | 1 |
| Chung, JL; Kim, BY; Lee, JH; Lim, EH; Mah, FS; Seo, KY; Song, SW | 1 |
| Carrijo-Carvalho, LC; Carvalho, FR; de Freitas, D; E Silva, FB; Teixeira, A | 1 |
| Allaire, CM; DeCory, HH; Sanfilippo, CM | 1 |
1 review(s) available for gatifloxacin and besifloxacin
| Article | Year |
|---|---|
Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Quinolines | 2012 |
2 trial(s) available for gatifloxacin and besifloxacin
| Article | Year |
|---|---|
Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Aza Compounds; Azepines; Biological Availability; Chromatography, Liquid; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Quinolines; Tandem Mass Spectrometry | 2011 |
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.
Topics: Anti-Bacterial Agents; Azepines; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Ophthalmic Solutions | 2017 |
10 other study(ies) available for gatifloxacin and besifloxacin
| Article | Year |
|---|---|
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; HEK293 Cells; Humans; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus | 2022 |
Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome | 2009 |
Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Treatment Outcome | 2010 |
Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Moxifloxacin; Ophthalmic Solutions; Penicillin Resistance; Pneumococcal Infections; Quinolines; Rabbits; Severity of Illness Index; Streptococcus pneumoniae; Time Factors | 2010 |
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Disease Susceptibility; DNA, Bacterial; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Sequence Analysis, DNA | 2011 |
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2010 |
In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.
Topics: Anti-Bacterial Agents; Aza Compounds; Azepines; Bacteria; Benzalkonium Compounds; Drug Interactions; Fluoroquinolones; Gatifloxacin; Microbial Viability; Moxifloxacin; Quinolines; Time Factors | 2011 |
Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Biological Availability; Chromatography, High Pressure Liquid; Conjunctiva; Cornea; Fluoroquinolones; Gatifloxacin; Levofloxacin; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Tissue Distribution; Vitreous Body | 2013 |
Toxicity of Intracameral Injection of Fourth-Generation Fluoroquinolones on the Corneal Endothelium.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Azepines; Cell Survival; Endothelium, Corneal; Fluoroquinolones; Gatifloxacin; Human Umbilical Vein Endothelial Cells; Humans; Injections, Intraocular; Male; Moxifloxacin; Ophthalmic Solutions; Rabbits; Topoisomerase II Inhibitors | 2016 |